Investigational Site Number: 6160002

Warsaw 02-953

0 studies enrolling now · 4 studies all time

What they study most

Dermatitis Atopic, Systemic Sclerosis, Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus, Type 2 Diabetes Mellitus

Studies at this site

• A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis — Completed
• Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine — Completed
• Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis — Completed
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early